He holds a Ph.D. in Biomedical Engineering from the University of Miami and a Master’s Degree in Materials Science and Chemical Engineering from the University of California, Irvine.

He is currently the Chairman and General Manager of the company. He has held various professional roles, including General Manager and Executive Director at Shenzhen Qianhai Junsheng Innovation Management from June 2016 to October 2021, and General Manager of Suzhou Shutong Medical from November 2021 to May 2025.

He earned an MBA from Cornell University and a Master's Degree from Tsinghua University’s PBC School of Finance.

He is currently the Deputy General Manager of the company. He has held various professional roles, including Deputy General Manager CICG Operations from August 2016 to April 2021, and Managing Director at Xinjin Shunzhi Investment Management (Ningbo) from May 2021 to July 2022. He has served as the Executive Director of Suzhou Xinsheng Huiming Private Equity Fund Management Co., Ltd. since August 2022.

He earned a Bachelor's Degree from Purdue University, USA, a Master's Degree from Washington University School of Medicine in St. Louis, USA and Durham University Business School, UK.

He has held various professional roles, including Medical Investment Partner at Shanghai Yonghua Investment Management Co., Ltd. since March 2020. At Suzhou Shutong Medical Technology Co., Ltd. since January 2020, Chengdu Serano Medical Technology Co., Ltd. since September 2021, Shanghai CureGene Pharmaceutical Co., Ltd. since June 2021, Suzhou Luosheng Biopharmaceutical Co., Ltd. since August 2021, Shanghai Kaiyitong Medical Technology Co., Ltd. since September 2022 served as a Non-Independent Director. Served as an Independent Director at Inventisbio Co., Ltd. since December 2020 and Genor Biopharma Holdings Limited since June 2020.

He holds a Bachelor's Degree in Tunnel and Underground Engineering from Tongji University. He has served as a Deputy Manager of Project Department at Shanghai Electric Power Generation Engineering Co. since August 2011.

She earned a Bachelor's Degree in Accounting and is certified as a Senior Accountant. She has served as a Chief Financial Officer at Zhejiang Aoxiang Pharmaceutical Co., Ltd. since July 2021.

He earned a Master's Degree in Law of University of International Business and Economics. He has served as a Lawyer and Director at Beijing Branch of JiaHua Law Firm since August 2020.

He earned a Bachelor's Degree of Xiamen University, a Master’s Degree of Fudan University.

He has held various professional roles, including the Partner at Beijing Jincheng Tongda & Neal (Shanghai) Law Firm from November 2015 to June 2024, the Partner at Beijing Dacheng (Shanghai) Law Offices since July 2024, Director at Shanghai Wo wo (Group) Co., Ltd. since July 2016, Supervisor at Shanghai Wanlianfa Development Co., Ltd. since September 2017, Independent Director at Tibet Urban Development and Investment Co., Ltd. (Stock Code: 600773) since May 2021, Supervisor at Precession (Wuxi) Smart Robotics Co., Ltd. since July 2024.